why choose us

Clinical Trials Search

Showing 12,520 of 132,366 result(s)
Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents

Status: Completed

Condition: Hiv

Interventions: PATHS is an intervention delivered to parents of AMSM that aims to increase parent communication about sexuality and HIV, as well as other parent beha

Date: 2023-05-02

Appetite Responses to Cereal Products

Status: COMPLETED

Condition: Satisfaction, Consumer

Interventions: Cereal products available in retail stores

Date: 2023-05-02

Allopurinol Improves Heart Function in African Americans With Resistant Hypertension

Status: Completed

Condition: Heart Failure Preserved Ejection Fraction

Interventions: Single arm of Allopurinol treatment for 300mg;daily for 4 weeks then increased to 600mg;daily for an additional 4 weeks.

Date: 2023-05-02

Evaluation of Oral Potentially Malignant Disorders (OPMDs) With STRATICYTE™

Status: Completed

Condition: Mouth Diseases

Interventions: Assessment for risk of progression to oral cancer

Date: 2023-05-02

Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) For Foreign-Born Arab Americans

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: Participants will complete an 8-week intervention, 2 sessions per week.
Co-INTEGRATE sessions take 30-50 minutes to complete.
Weekly on the

Date: 2023-05-02

A Study of BION-1301 in Adults With IgA Nephropathy

Status: Completed

Condition: IgA Nephropathy

Interventions: BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks.

Date: 2023-05-02

Evaluation of Clareon Vivity;Vivity Toric

Status: COMPLETED

Condition: Aphakia

Interventions: Extended vision intraocular lens implanted in the capsular bag of the eye during cataract surgery.
IOLs are intended for long term use over the l

Date: 2023-05-02

To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia

Status: Completed

Condition: Severe Hypertriglyceridemia

Interventions: Subcutaneous injection

Date: 2023-05-02

Study of MK-0472 in Participants With Advanced;Metastatic Solid Tumors (MK-0472-001)

Status: Completed

Condition: Metastatic Solid Tumors

Interventions: Oral Administration

Date: 2023-05-02

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

Status: Completed

Condition: Blastoid Variant Mantle Cell Lymphoma

Interventions: Undergo tumor biopsy

Date: 2023-05-01